Investment analysts at StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS stock opened at $0.15 on Friday. Pieris Pharmaceuticals has a one year low […]
Shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 31,577 shares traded hands during trading, an increase of 316% from the previous session’s volume of 7,598 shares.The stock last traded at $11.65 and had previously closed at $11.69. Analyst Ratings Changes Separately, StockNews.com initiated coverage on […]
Equities research analysts at StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a report released on Sunday. The firm set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of PIRS stock opened at $0.15 on Friday. The business’s fifty day moving average price is […]
Pieris Pharmaceuticals (NASDAQ:PIRS) Receives New Coverage from Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Up 8.3 % Shares of PIRS opened at $0.17 on Friday. The company’s fifty day simple moving average is $0.17 and its 200-day […]